-
Je něco špatně v tomto záznamu ?
Atrial fibrillation in critical illness: state of the art
S. Sibley, J. Bedford, M. Wetterslev, B. Johnston, T. Garside, S. Kanji, T. Whitehouse, I. Welters, M. Ostermann, M. Balik, D. Lancini, B. Dharmaraj, EJ. Benjamin, AJ. Walkey, BH. Cuthbertson
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, přehledy
- MeSH
- fibrilace síní * terapie patofyziologie komplikace MeSH
- hodnocení rizik MeSH
- kritický stav * terapie MeSH
- lidé MeSH
- rizikové faktory MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Atrial fibrillation (AF) is the most common arrhythmia experienced by critically ill patients. It has been associated with adverse short-and long-term outcomes, including an increased risk of thromboembolic events, heart failure, and death. Due to complex and multifactorial pathophysiology, a heterogenous patient population, and a lack of clinical tools for risk stratification validated in this population, AF in critical illness is challenging to predict, prevent, and manage. Personalized management strategies that consider patient factors such as underlying cardiac structure and function, potentially reversible arrhythmogenic triggers, and risk for complications of AF are needed. Furthermore, evaluation of the effects of these interventions on long-term outcomes is warranted. Critical illness survivors who have had AF represent a unique population who require systematic follow-up after discharge. However, the frequency, type, and intensity of follow-up is unknown. This state-of-the-art review aims to summarize the evidence, contextualize the current guidelines within the setting of critical illness, and highlight gaps in knowledge and research opportunities to further our understanding of this arrhythmia and improve patient outcomes.
Cardiology Department Royal Brisbane and Women's Hospital Brisbane QLD Australia
Department of Clinical Neurosciences University of Oxford Nuffield Oxford UK
Department of Critical Care Medicine Queen's University Kingston Canada
Department of Critical Care Medicine Sunnybrook Health Sciences Centre Bayview Avenue Toronto Canada
Department of Epidemiology School of Public Health Boston University Boston USA
Department of Intensive Care Rigshospitalet University of Copenhagen Copenhagen Denmark
Faculty of Medicine University of Queensland Brisbane QLD Australia
Institute of Inflammation and Ageing University of Birmingham Birmingham UK
JohnMoores University and Liverpool Heart and Chest Hospital Liverpool UK
King's College London Guy's and St Thomas' Hospital London London UK
Liverpool Centre for Cardiovascular Science University of Liverpool Liverpool UK
Management and Evaluation Institute for Health Policy University of Toronto Toronto Canada
Michael G DeGroote School of Medicine McMaster University Hamilton Canada
The George Institute for Global Health Sydney Australia
The Ottawa Hospital Research Institute Ottawa Canada
University Hospitals of Birmingham NHS Foundation Trust Queen Elizabeth Hospital Birmingham UK
University of Sydney Royal North Shore Hospital Sydney Australia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25015834
- 003
- CZ-PrNML
- 005
- 20250731091246.0
- 007
- ta
- 008
- 250708s2025 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00134-025-07895-0 $2 doi
- 035 __
- $a (PubMed)40323451
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Sibley, Stephanie $u Department of Critical Care Medicine, Queen's University, Kingston, Canada. stephanie.sibley@kingstonhsc.ca $1 https://orcid.org/0000000322299747
- 245 10
- $a Atrial fibrillation in critical illness: state of the art / $c S. Sibley, J. Bedford, M. Wetterslev, B. Johnston, T. Garside, S. Kanji, T. Whitehouse, I. Welters, M. Ostermann, M. Balik, D. Lancini, B. Dharmaraj, EJ. Benjamin, AJ. Walkey, BH. Cuthbertson
- 520 9_
- $a Atrial fibrillation (AF) is the most common arrhythmia experienced by critically ill patients. It has been associated with adverse short-and long-term outcomes, including an increased risk of thromboembolic events, heart failure, and death. Due to complex and multifactorial pathophysiology, a heterogenous patient population, and a lack of clinical tools for risk stratification validated in this population, AF in critical illness is challenging to predict, prevent, and manage. Personalized management strategies that consider patient factors such as underlying cardiac structure and function, potentially reversible arrhythmogenic triggers, and risk for complications of AF are needed. Furthermore, evaluation of the effects of these interventions on long-term outcomes is warranted. Critical illness survivors who have had AF represent a unique population who require systematic follow-up after discharge. However, the frequency, type, and intensity of follow-up is unknown. This state-of-the-art review aims to summarize the evidence, contextualize the current guidelines within the setting of critical illness, and highlight gaps in knowledge and research opportunities to further our understanding of this arrhythmia and improve patient outcomes.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a fibrilace síní $x terapie $x patofyziologie $x komplikace $7 D001281
- 650 12
- $a kritický stav $x terapie $7 D016638
- 650 _2
- $a hodnocení rizik $7 D018570
- 650 _2
- $a rizikové faktory $7 D012307
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Bedford, Jonathan $u Department of Clinical Neurosciences, University of Oxford Nuffield, Oxford, UK
- 700 1_
- $a Wetterslev, Mik $u Department of Intensive Care, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
- 700 1_
- $a Johnston, Brian $u Faculty of Health, and Life Sciences, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK $u Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool, UK $u JohnMoores University and Liverpool Heart and Chest Hospital, Liverpool, UK
- 700 1_
- $a Garside, Tessa $u University of Sydney, Royal North Shore Hospital, Sydney, Australia $u The George Institute for Global Health, Sydney, Australia
- 700 1_
- $a Kanji, Salmaan $u The Ottawa Hospital Research Institute, Ottawa, Canada
- 700 1_
- $a Whitehouse, Tony $u University Hospitals of Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Birmingham, UK $u Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK
- 700 1_
- $a Welters, Ingeborg $u Faculty of Health, and Life Sciences, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK $u Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool, UK
- 700 1_
- $a Ostermann, Marlies $u King's College London, Guy's and St Thomas' Hospital London, London, UK
- 700 1_
- $a Balik, Martin $u Faculty of Medicine, Department of Anesthesiology and Intensive Care, Charles University, Prague, Czechia
- 700 1_
- $a Lancini, Daniel $u Cardiology Department, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia $u Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia
- 700 1_
- $a Dharmaraj, Blossom $u Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Canada
- 700 1_
- $a Benjamin, Emelia J $u Department of Epidemiology, School of Public Health, Boston University, Boston, USA $u Department of Medicine, Cardiovascular Medicine Section, Boston Medical Center and Boston University Chobanian and Avedisian School of Medicine, Boston, USA
- 700 1_
- $a Walkey, Allan J $u Division of Health Systems Science, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, USA
- 700 1_
- $a Cuthbertson, Brian H $u Temerty Faculty of Medicine, Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, Canada $u Management and Evaluation, Institute for Health Policy, University of Toronto, Toronto, Canada $u Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Bayview Avenue, Toronto, Canada
- 773 0_
- $w MED00002258 $t Intensive care medicine $x 1432-1238 $g Roč. 51, č. 5 (2025), s. 904-916
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40323451 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250708 $b ABA008
- 991 __
- $a 20250731091240 $b ABA008
- 999 __
- $a ok $b bmc $g 2366572 $s 1252959
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 51 $c 5 $d 904-916 $e 20250505 $i 1432-1238 $m Intensive care medicine $n Intensive Care Med $x MED00002258
- LZP __
- $a Pubmed-20250708
